荟萃分析
胆固醇
置信区间
内科学
医学
随机对照试验
血脂谱
胃肠病学
临床试验
高密度脂蛋白
脂蛋白
内分泌学
作者
Zijian Guo,X.M. Liu,Q.X. Zhang,Zongshan Shen,Fengwei Tian,Haihua Zhang,Zhihong Sun,H.P. Zhang,Wei Chen
标识
DOI:10.1016/j.numecd.2011.04.008
摘要
Abstract
Aims
Human clinical studies have yielded mixed results on the effects of consumption of probiotics on the plasma lipid profile. We conducted a meta-analysis of randomised controlled trials that evaluated the effects of probiotics consumption on blood lipids. Data Synthesis
A systematic literature search of Embase, Web of Science, PubMed and Cochrane Controlled Trials Registry was conducted for studies that investigated the efficacy of probiotics on the plasma lipid profile of subjects. With the help of Review Manager 4.2, data from 13 trials, which included 485 participants with high, borderline high and normal cholesterol levels, were examined. The pooled mean net change in total cholesterol for those treated with probiotics compared to controls was −6.40 mg dl−1 (95% confidence interval (CI), −9.93 to −2.87), mean net change in low-density lipoprotein (LDL) cholesterol was −4.90 mg dl−1 (95% CI, −7.91 to −1.90), mean net change in high-density lipoprotein (HDL) cholesterol was −0.11 mg dl−1 (95% CI, −1.90–1.69) and mean net change in triglycerides was −3.95 mg dl−1 (95% CI, −10.32–2.42). Conclusion
These results indicate that a diet rich in probiotics decreases total cholesterol and LDL cholesterol concentration in plasma for participants with high, borderline high and normal cholesterol levels.
科研通智能强力驱动
Strongly Powered by AbleSci AI